← Special Reports
CardiologyHeart Failure

Cardio-Renal-Metabolic Syndrome: How a New Diagnosis Changes Everything

The AHA renamed the disease. Now every cardiologist, nephrologist, and endocrinologist must collaborate

SR-2026-019
EditorMara Voss
CopywritersEditorial Team
Coming Soon

Cardio-Renal-Metabolic Syndrome: How a New Diagnosis Changes Everything

The AHA renamed the disease. Now every cardiologist, nephrologist, and endocrinologist must collaborate

Why We Are Covering This

The American Heart Association formally recognized CRM syndrome as a unified disease framework in 2024, and updated 2025 guidelines are already in conflict with how most health systems are organized. Three specialties are now being asked to coordinate care they were never structured to share.

What to Expect

You will leave with a cross-specialty management framework for CRM syndrome, clarity on how SGLT2 inhibitors, finerenone, and GLP-1 agents are positioned across all three organ systems, and the commercial implications of unified care pathways.

Be first when this report publishes

The Life Science Feed briefing covers every major trial readout, approval, and pipeline shift, weekly.

Get the briefing first
The Life Science Feed
thelifesciencefeed.com · Special Report
SR-2026-01907/26
    0:00 / 0:00